SHCBP1 is not only an effective prognostic indicator but also a potential biological treatment target, which was confirmed in this study of tumour data collected from three different clinical sources (TCGA database, Union Hospital clinical sample, and out-of-hospital tissue array). Here, SHCBP1 is linked to neoplasm.